Expert Video - Who is eligible for TIL therapy? What are the criteria?
Rekha Chaudhary, MD, a hematologist and oncologist who specializes in the treatment of melanoma at the University of Cincinnati, explains some of the important criteria that make a melanoma patient eligible for tumor infiltrating lymphocyte (TIL) therapy. Patients need a tumor large enough and accessible enough to biopsy for TIL therapy. They also need to be healthy enough to undergo the chemotherapy, or lymphodepletion, as well as the IL-2 infusions to receive the TIL therapy.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about melanoma which will help other patients, caregivers and families.
Animation - TIL Cell Therapy for Melanoma
Slide Show - TIL Cell Therapy for Melanoma
1.
Who is eligible for TIL therapy? What are the criteria?
2.
Why is TIL therapy effective to treat melanoma?
3.
What happens to my tumor sample after the biopsy?
4.
Why do I need chemotherapy to prepare for the TIL therapy?
5.
What side effects can I expect after receiving chemotherapy to prepare for the TIL infusion?
6.
What side effects can I expect after the TIL cells are infused back into me?
7.
How will I know if my melanoma has responded to TIL therapy?
8.
Why might TIL therapy not be recommended for me?
